Multicenter Phase I/II Study of Nivolumab Combined with Paclitaxel Plus Ramucirumab As Second-line Treatment in Patients with Advanced Gastric Cancer
pubmed（2023）
Key words
Gastric Cancer
AI Read Science
Must-Reading Tree
Example
Generate MRT to find the research sequence of this paper
Chat Paper
Summary is being generated by the instructions you defined